
Nicole Baranda Balmaceda, MD
@nbalmacedamd
Hematology/Oncology Fellow Physician at the University of Colorado | 5'2" on a good day | Loves lumpia @CuHemeOnc | Millennial dog mom to Nivo #gioncology
ID: 1778911774038781953
12-04-2024 22:23:19
58 Tweet
85 Followers
241 Following



The Spring 2024 FDA-ASCO Fellows Day Workshop was a great success! We always enjoy meeting talented people at the start of their careers who represent the future of oncology! #OCEProjectSocrates #MedEd Tatiana Prowell, MD Jennifer Gao @suparnawedam Timil Patel, MD Rick Pazdur


#ASCO24 will reveal data from many practice changing trials including a plenary for Gastroesophageal cancers. Sunnie Kim, MD Kelsey Klute and myself will present an educational session ASCO. Here's the article: ascopubs.org/doi/10.1200/ED… Nicole Baranda Balmaceda, MD Angelica Petrillo Joseph J Zhao

On June 4, please come to our educational session on the current and future state of gastroesophageal cancer treatment at #ASCO24. Proud of our phenomenal fellow Nicole Baranda Balmaceda, MD who first authored this publication. Kelsey Klute Raghav Sundar CU Anschutz Hematology/Oncology Fellowship CU Cancer Center

So proud to have been part of this wonderful team Raghav Sundar Nicole Baranda Balmaceda, MD 💪🏻 Please take a 👀 at this paper on #biomarkers in #gastric cancer just published in ASCO educational book #ASCO24


A wonderful #ASCO24 presentation by Drs Sunnie Kim, Raghav Sundar, and Kelsey Klute! “State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care” Sunnie Kim, MD Raghav Sundar Kelsey Klute CU Cancer Center

Join us tomorrow for a fun discussion on CLDN18.2 🎯 in gastric cancer! 🎉Sunnie Kim, MD CU Cancer Center CU Anschutz Hematology/Oncology Fellowship #TumorBoardTuesday


Thank you, Sunnie Kim, MD for mentoring me! If you are coming to GI ASCO, come say hi Thursday. CU Anschutz Hematology/Oncology Fellowship CU Cancer Center CU Department of Medicine ASCO


Today, our talented CU Anschutz Hematology/Oncology Fellowship fellow Nicole Baranda Balmaceda, MD is presenting our work on the association of Abx and survival outcomes in 1L IO based therapies for gastroesophageal cancers.


Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced GC/GEJ cancer The Lancet Oncology doi.org/10.1016/S1470-… 🔎 KYM901 phs 1 trial 👉ORR 29%, DCR 68% 👉SAE ≥3 68% 👉first CLDN18.2- specific ADC 🧐Phs 3 ongoing... ESMO - Eur. Oncology
